Lymph directing prodrugs
US11311512B2 · kind B2 · utility
3Cited by
13References
50Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 12, 2015 |
| Grant date | Apr 26, 2022 |
| Priority date | — |
| Expiry date | May 7, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC09J5/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds and their uses, in particular, compounds in the form of prodrugs that promote transport of a pharmaceutical agent to the lymphatic system and subsequently enhance release of the parent drug.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.